뉴욕의 골수섬유증 임상 시험
골수섬유증 관련 연구 23개가 뉴욕 내 여러 지역에서 참여자를 모집하고 있습니다.
뉴욕의 도시
공식 연구 텍스트(영어)
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai School of Medicine, New York
- Weill Cornell Medicine, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07441694A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
- New York Oncology Hematology P C, Albany
- Columbia University Medical Center New York Presbyterian, New York
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07357727A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering, New York
- Icahn School of Medicine at Mount Sinai, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06343805A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07623161Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
- GSK Investigational Site, New York
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06517875A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
- NYP/Weill Cornell Medical Center, New York
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06661915A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
- Site US17, Babylon
- Site US01, New York
- Site US02, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07849231Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias
- Icahn School of Medicine at Mount Sinai, New York
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07447817Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore, New York
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT05320198Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
- Columbia University, New York
- Montefiore Einstein Cancer Center, The Bronx
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT05423691A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical Center, New York
- 외 1개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04176198A Telehealth Advance Care Planning Intervention
- University of Rochester, Rochester
피험자 모집 중
60세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT05875805A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
- Icahn School of Medicine At Mount Sinai, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT07008118A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- 외 1개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT06773195Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
- Wilmot Cancer Institute, University of Rochester, Rochester
피험자 모집 중초기 1상
18세 ~ 75세 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT03964506Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
- Roswell Park Cancer Institute, Buffalo
- Ruttenberg Treatment Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- 외 1개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT05835466A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 4. 17. 업데이트됨 · NCT06034002A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Memorial Sloan Kettering, New York
피험자 모집 중2상
18세 ~ 66세 · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT06859424A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- Weill Cornell Medicine NewYork-Presbyterian, New York
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 2. 12. 업데이트됨 · NCT05980806MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
- Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 1. 23. 업데이트됨 · NCT07362225MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
- Ruttenberg Treatment Center, New York
피험자 모집 중2상
18세 이상 · 모든 성별 · 2025. 12. 17. 업데이트됨 · NCT06541249SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- 외 2개
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
- Brookdale University Hospital and Medical Center, Brooklyn
- Cayuga Cancer Center, Ithaca
- Northwell Health, R.J. Zuckerberg Cancer Center, Lake Success
- 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2025. 9. 25. 업데이트됨 · NCT06479135ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.